Back to Search
Start Over
Analysis of risk factors for multidrug-resistant pathogens and appropriate treatment indications for pneumonia in children with neurologic impairment
- Source :
- Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 27(2)
- Publication Year :
- 2020
-
Abstract
- Introduction The features of pneumonia in children with neurologic impairment (NI) resemble those of healthcare-associated pneumonia is defined as pneumonia occurring in the community associated with healthcare risk factors. There are currently no guidelines for the treatment of pneumonia in children with NI. Here, we assessed whether the guidelines applicable for treating pneumonia in adults could be applied to children with NI. Methods Between 2008 and 2019, we enrolled children with NI who developed pneumonia and were treated in the pediatric ward of Kawasaki Medical School Hospital. We evaluated patient characteristics, the frequency of isolation of multidrug-resistant (MDR) pathogens, and clinical outcomes. Results MDR pathogens were more frequently isolated from patients receiving tube feeding (TF) and/or with tracheostomy than from patients without these risk factors. Other risk factors, including a history of antibiotic therapy and methicillin-resistant Staphylococcus aureus isolation, recent hospitalization, residence in a nursing home or extended care facility, and low-dose, long-term macrolide therapy, did not significantly affect the frequency of MDR pathogen isolation. In patients receiving TF and/or with tracheostomy, treatment success was achieved in all cases treated with broad-spectrum antibiotics and 72.2% of cases treated with non-broad-spectrum antibiotics (P = 0.007). Conversely, among patients without these risk factors, no such difference was observed. Conclusions Our findings indicate that the guideline to select antibiotics for treating pneumonia in children with NI should be simpler and more useful than the current guidelines for adult pneumonia, based on risk factor assessment for MDR pathogens.
- Subjects :
- 0301 basic medicine
Microbiology (medical)
Adult
Methicillin-Resistant Staphylococcus aureus
medicine.medical_specialty
Isolation (health care)
medicine.drug_class
030106 microbiology
Antibiotics
medicine.disease_cause
03 medical and health sciences
0302 clinical medicine
Risk Factors
Internal medicine
Drug Resistance, Multiple, Bacterial
medicine
Humans
Pharmacology (medical)
030212 general & internal medicine
Risk factor
Child
Pathogen
Cross Infection
business.industry
Guideline
Pneumonia
medicine.disease
Anti-Bacterial Agents
Multiple drug resistance
Infectious Diseases
Staphylococcus aureus
business
Subjects
Details
- ISSN :
- 14377780
- Volume :
- 27
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
- Accession number :
- edsair.doi.dedup.....358a659cb265bd7ea7eb8a8d011ca2af